Analyse de série chronologique interrompue : Questions médicales fréquentes
Nom anglais: Interrupted Time Series Analysis
Descriptor UI:D065186
Tree Number:N06.850.520.450.500.912
Termes MeSH sélectionnés :
Meta-Analysis as Topic
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Analyse de série chronologique interrompue : Questions médicales les plus fréquentes",
"headline": "Analyse de série chronologique interrompue : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Analyse de série chronologique interrompue : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-04",
"dateModified": "2025-04-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Analyse de série chronologique interrompue"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Études épidémiologiques",
"url": "https://questionsmedicales.fr/mesh/D016021",
"about": {
"@type": "MedicalCondition",
"name": "Études épidémiologiques",
"code": {
"@type": "MedicalCode",
"code": "D016021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Analyse de série chronologique interrompue",
"alternateName": "Interrupted Time Series Analysis",
"code": {
"@type": "MedicalCode",
"code": "D065186",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jürgen Rehm",
"url": "https://questionsmedicales.fr/author/J%C3%BCrgen%20Rehm",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Shannon Lange",
"url": "https://questionsmedicales.fr/author/Shannon%20Lange",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Y Li",
"url": "https://questionsmedicales.fr/author/Y%20Li",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Medical Virology and Viral Diseases of National Health Commission, National Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China."
}
},
{
"@type": "Person",
"name": "S C Yu",
"url": "https://questionsmedicales.fr/author/S%20C%20Yu",
"affiliation": {
"@type": "Organization",
"name": "Office of Epidemiology, Chinese Center for Disease Control and Prevention, Beijing 102206, China."
}
},
{
"@type": "Person",
"name": "C G Jin",
"url": "https://questionsmedicales.fr/author/C%20G%20Jin",
"affiliation": {
"@type": "Organization",
"name": "School of Social Development and Public Policy, Beijing Normal University, Beijing 100875, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Anti-sperm Antibody Positivity in Men with Varicocele: A Systematic Review and Meta-Analysis.",
"datePublished": "2024-04-04",
"url": "https://questionsmedicales.fr/article/38606868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5534/wjmh.240003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis.",
"datePublished": "2024-04-04",
"url": "https://questionsmedicales.fr/article/38638136",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2024.1368079"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of obesity in religious clergy in the United States: A systematic review and meta-analysis.",
"datePublished": "2024-04-04",
"url": "https://questionsmedicales.fr/article/38572610",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/obr.13741"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prognostic factors for resected cases with gallbladder carcinoma: A systematic review and meta-analysis.",
"datePublished": "2024-04-03",
"url": "https://questionsmedicales.fr/article/38537060",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/JS9.0000000000001403"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Prevalence of burnout syndrome in physicians working in Spain: systematic review and meta-analysis].",
"datePublished": "2024-04-02",
"url": "https://questionsmedicales.fr/article/38653640",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.gaceta.2024.102384"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Caractéristiques des études épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D016020"
},
{
"@type": "ListItem",
"position": 6,
"name": "Études épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D016021"
},
{
"@type": "ListItem",
"position": 7,
"name": "Analyse de série chronologique interrompue",
"item": "https://questionsmedicales.fr/mesh/D065186"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Analyse de série chronologique interrompue - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Analyse de série chronologique interrompue",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Analyse de série chronologique interrompue",
"description": "Comment identifier une série chronologique interrompue ?\nQuels outils sont utilisés pour l'analyse ?\nQuelles données sont nécessaires pour l'analyse ?\nComment évaluer la validité des résultats ?\nQuels biais peuvent affecter l'analyse ?",
"url": "https://questionsmedicales.fr/mesh/D065186?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Analyse de série chronologique interrompue",
"description": "Quels symptômes peuvent être analysés ?\nComment les symptômes évoluent-ils après une intervention ?\nPeut-on mesurer des symptômes subjectifs ?\nLes symptômes sont-ils influencés par des facteurs externes ?\nComment les symptômes sont-ils collectés ?",
"url": "https://questionsmedicales.fr/mesh/D065186?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Analyse de série chronologique interrompue",
"description": "Comment l'analyse aide-t-elle à la prévention ?\nQuels programmes peuvent être analysés ?\nComment mesurer l'impact d'une campagne de prévention ?\nQuels indicateurs de prévention sont pertinents ?\nPeut-on évaluer des interventions non médicales ?",
"url": "https://questionsmedicales.fr/mesh/D065186?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Analyse de série chronologique interrompue",
"description": "Quels traitements peuvent être évalués par cette méthode ?\nComment mesurer l'efficacité d'un traitement ?\nPeut-on comparer plusieurs traitements ?\nQuels indicateurs de traitement sont utilisés ?\nComment les effets secondaires sont-ils pris en compte ?",
"url": "https://questionsmedicales.fr/mesh/D065186?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Analyse de série chronologique interrompue",
"description": "Quelles complications peuvent être analysées ?\nComment les complications sont-elles mesurées ?\nLes complications sont-elles influencées par le temps ?\nPeut-on prédire des complications futures ?\nComment gérer les complications identifiées ?",
"url": "https://questionsmedicales.fr/mesh/D065186?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Analyse de série chronologique interrompue",
"description": "Quels facteurs de risque peuvent être analysés ?\nComment les facteurs de risque influencent-ils les résultats ?\nPeut-on identifier des facteurs de risque modifiables ?\nComment les facteurs de risque sont-ils mesurés ?\nLes facteurs de risque changent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D065186?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier une série chronologique interrompue ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut observer des changements significatifs dans les données après une intervention."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour l'analyse ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des logiciels statistiques comme R ou SAS sont souvent utilisés pour l'analyse."
}
},
{
"@type": "Question",
"name": "Quelles données sont nécessaires pour l'analyse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des données chronologiques avant et après l'intervention sont essentielles."
}
},
{
"@type": "Question",
"name": "Comment évaluer la validité des résultats ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut vérifier la robustesse des résultats par des tests de sensibilité."
}
},
{
"@type": "Question",
"name": "Quels biais peuvent affecter l'analyse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biais de sélection et de mesure peuvent fausser les résultats."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent être analysés ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fréquence des hospitalisations ou des décès peuvent être mesurés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils après une intervention ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse peut montrer une diminution ou une augmentation des symptômes post-intervention."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer des symptômes subjectifs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des échelles de mesure peuvent évaluer des symptômes subjectifs comme la douleur."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils influencés par des facteurs externes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme la saisonnalité peuvent influencer les symptômes observés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils collectés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être collectés par des enquêtes, des dossiers médicaux ou des observations."
}
},
{
"@type": "Question",
"name": "Comment l'analyse aide-t-elle à la prévention ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'évaluer l'impact des programmes de prévention sur des résultats de santé."
}
},
{
"@type": "Question",
"name": "Quels programmes peuvent être analysés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de vaccination, de dépistage ou d'éducation à la santé peuvent être évalués."
}
},
{
"@type": "Question",
"name": "Comment mesurer l'impact d'une campagne de prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact est mesuré par des changements dans les comportements ou les taux de maladies."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de prévention sont pertinents ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des indicateurs comme le taux d'incidence ou de prévalence des maladies sont pertinents."
}
},
{
"@type": "Question",
"name": "Peut-on évaluer des interventions non médicales ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interventions comme des changements de politique ou d'environnement peuvent être analysées."
}
},
{
"@type": "Question",
"name": "Quels traitements peuvent être évalués par cette méthode ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements médicaux, chirurgicaux ou comportementaux peuvent être analysés."
}
},
{
"@type": "Question",
"name": "Comment mesurer l'efficacité d'un traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est mesurée par des changements dans les résultats cliniques après l'intervention."
}
},
{
"@type": "Question",
"name": "Peut-on comparer plusieurs traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'analyse peut comparer l'impact de différents traitements sur les mêmes résultats."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de traitement sont utilisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des indicateurs comme le taux de guérison ou la réduction des symptômes sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment les effets secondaires sont-ils pris en compte ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires doivent être mesurés et analysés pour évaluer la sécurité du traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent être analysées ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme les infections ou les effets indésirables des traitements peuvent être évaluées."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles mesurées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont mesurées par des taux d'incidence ou des événements indésirables rapportés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles influencées par le temps ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent varier selon la période de suivi après l'intervention."
}
},
{
"@type": "Question",
"name": "Peut-on prédire des complications futures ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse peut aider à prédire des complications en fonction des tendances observées."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications identifiées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des stratégies de gestion doivent être mises en place pour minimiser les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque peuvent être analysés ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, le sexe, et les comorbidités peuvent être évalués."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque influencent-ils les résultats ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent modifier l'impact d'une intervention sur les résultats de santé observés."
}
},
{
"@type": "Question",
"name": "Peut-on identifier des facteurs de risque modifiables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'analyse peut aider à identifier des facteurs de risque qui peuvent être modifiés."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque sont-ils mesurés ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont mesurés par des questionnaires, des dossiers médicaux ou des études épidémiologiques."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque changent-ils avec le temps ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les facteurs de risque peuvent évoluer en fonction des changements environnementaux ou sociaux."
}
}
]
}
]
}
Despite the significant role of varicocele in the pathogenesis of male infertility, its association with anti-sperm antibodies (ASA) remains controversial. This systematic review and meta-analysis (SR...
This SRMA is conducted in accordance with the Meta-analysis of Observational Studies in Epidemiology guidelines. We investigated the frequency of ASA positivity in ejaculates or serum of men with vari...
Out of 151 abstracts identified during the initial screening, 6 articles met the inclusion criteria and were included in the meta-analysis. Using mixed antiglobulin reaction (MAR) assay, 61 out of the...
This SRMA indicates that ASA positivity is significantly higher among men with varicocele when tested by direct method (MAR) or indirect method (ELISA). This data suggests an immunological pathology i...
Previous studies have established that diabetes mellitus (DM) markedly raises the risk of developing erectile dysfunction (ED). Despite extensive investigations, the risk factors associated with ED in...
The objective of this systematic review and meta-analysis was to assess the risk factors for ED in men with DM....
A comprehensive systematic review was conducted, encompassing studies published in the PubMed, Scopus and Embase databases up to August 24th, 2023. All studies examining the risk factors of ED in pati...
A total of 58 studies, including a substantial participant pool of 66,925 individuals diagnosed with DM, both with or without ED, were included in the meta-analysis. Mean age (OR: 1.31, 95% CI=1.24-1....
Our study indicates that in men with DM, several risk factors for ED have been identified, including mean age, HbA1C, duration of DM, diabetic neuropathy, diabetic retinopathy, diabetic foot, cardiova...
This systematic review aims to summarize the current body of evidence concerning the prevalence of obesity among clergy (i.e., the officially designated leaders of a religious group) in the United Sta...
From November 2022 to February 2023, five databases, one data repository, and gray matter were searched for articles and data sources. The search was restricted to articles published or raw data colle...
Forty-seven studies of clergy obesity involving 35,064 individuals were eligible. The pooled prevalence estimate of obesity across studies was 34.8% (95% confidence interval [CI]: 32.5-37.2). Obesity ...
Current meta-analysis was performed to systematically evaluate the potential prognostic factors for overall survival (OS) among resected cases with gallbladder carcinoma (GBC)....
PubMed, EMBASE, and the Cochrane Library were systematically retrieved and hazard ratio (HR) and its 95% confidence interval (CI) were directly extracted from the original study or roughly estimated v...
A total of 36 studies with 11502 cases were identified. Pooled results of univariate analyses indicated that advanced age (HR=1.02, P=0.00020), concurrent gallstone disease (HR=1.22, P=0.00200), eleva...
Various prognostic factors have been identified beyond the 8th AJCC staging system. By incorporating these factors into a prognostic model, a more individualized prognostication and treatment regime w...
To analyze the prevalence of burnout syndrome in physicians working in Spain through a systematic review with meta-analysis METHOD: We searched PubMed/MEDLINE, Embase, and PsycINFO (up to June 2023). ...
Sixty-seven studies with 16,076 participants were included. For the primary outcome, the meta-analysis revealed a global prevalence of burnout in physicians of 24% (95%CI: 19%-29%; 46 studies; 8821 pa...
A high prevalence of burnout syndrome was found in physicians working in Spain. These results can contribute to estimating the burden associated with burnout in physicians at a national level and to t...
Open Science Framework: https://osf.io/b2h4m/....
The elucidation of synaptic density changes provides valuable insights into the underlying brain mechanisms of substance use. In preclinical studies, synaptic density markers, like spine density, are ...
This comprehensive meta-analysis investigates the association between olfactory deficits in mild cognitive impairment (MCI) and Alzheimer's disease (AD)....
A thorough search across databases identified articles analyzing olfactory status in MCI or AD patients. Methodological quality assessment followed PRISMA guidelines. Hedges' g effect size statistic c...
Among the included studies (65 for MCI and 61 for AD), odor identification exhibited larger effect sizes compared to odor threshold and discrimination, in both MCI and AD samples. Moderate effect size...
Olfactory impairments exhibit a notable and substantial presence in MCI. Among these impairments, odor identification experiences the greatest decline in MCI, mirroring the primary sensory deficit obs...
To systematically investigate and analyse the aggregated data from recent studies to provide a quantitative synthesis for a conservative approach to the management of high-grade kidney trauma, as accu...
A comprehensive search was performed using databases, including PubMed, EBSCO, ProQuest, Google Scholar, and Cochrane Library, to identify studies relevant to high-grade renal trauma in both adult and...
A total of 36 and 29 studies were included for qualitative and quantitative synthesis, respectively. The aggregated data showed a cumulative risk difference of 0.52 (95% confidence interval [CI] 0.38-...
The results indicate that opting for conservative management in cases of high-grade renal trauma, particularly for haemodynamically stable patients, presents a lower risk of mortality and reduced prob...
The aim of this study was to evaluate the diagnostic characteristics of biomarker for diabetic foot osteomyelitis (DFO). We searched PubMed, Scopus, Embase and Medline for studies who report serologic...
Idiopathic membranous nephropathy (IMN) is a rare autoimmune disorder that causes nephrotic syndromes in adults. Conventional immunosuppressive therapies often exhibit limited efficacy in achieving re...
This study aimed to examine the safety and efficacy of TCM alone or in combination with Western medicine for the management of patients diagnosed with IMN....
This study employed a systematic search of English and Chinese electronic databases to identify randomized controlled trials (RCTs) that examined the application of TCM in the treatment of IMN. RCTs t...
This study included 29 randomized controlled trials (RCTs) involving 1982 patients with moderate methodological quality that met the inclusion criteria. The results showed that, compared to Western me...
The results of this study suggest that TCM alone or in combination with Western medicine may be a feasible alternative therapeutic approach for the treatment of IMN. Nevertheless, additional, rigorous...